RP
TMO icon

Riverwater Partners’s Thermo Fisher Scientific TMO Stock Holding History

Riverwater Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Buy
2,365
+57
+2% +$30.9K 0.39% 82
2025
Q4 		$1.34M Buy
2,308
+106
+5% +$59.9K 0.52% 66
2025
Q3 		$1.07M Buy
2,202
+275
+14% +$128K 0.44% 68
2025
Q2 		$781K Buy
1,927
+267
+16% +$112K 0.37% 87
2025
Q1 		$826K Sell
1,660
-152
-8% -$82.3K 0.42% 74
2024
Q4 		$943K Buy
1,812
+91
+5% +$50K 0.46% 64
2024
Q3 		$1.05M Sell
1,721
-27
-2% -$16K 0.52% 60
2024
Q2 		$967K Sell
1,748
-28
-2% -$16K 0.72% 35
2024
Q1 		$1.03M Sell
1,776
-17
-0.9% -$9.54K 0.76% 27
2023
Q4 		$952K Buy
1,793
+14
+0.8% +$6.78K 0.75% 28
2023
Q3 		$900K Sell
1,779
-12
-0.7% -$6.39K 0.82% 28
2023
Q2 		$934K Sell
1,791
-13
-0.7% -$7.01K 0.83% 29
2023
Q1 		$1.04M Sell
1,804
-551
-23% -$311K 0.95% 22
2022
Q4 		$1.3M Buy
2,355
+111
+5% +$58.8K 1.11% 19
2022
Q3 		$1.14M Buy
2,244
+157
+8% +$87.9K 1.14% 15
2022
Q2 		$1.13M Buy
2,087
+1,085
+108% +$597K 1.14% 11
2022
Q1 		$592K Sell
1,002
-1,156
-54% -$664K 0.98% 43
2021
Q4 		$1.44M Buy
+2,158
New +$1.35M 1.28% 9

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Riverwater Partners's TMO Position: Q1 2026 in Review

Riverwater Partners increased its Thermo Fisher Scientific (TMO) stake by 2.5% in Q1 2026, buying an estimated $30.9K and bringing the position to 2,365 shares worth $1.16M. The position accounts for 0.39% of the portfolio, ranked #82.

Riverwater Partners first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.44M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Riverwater Partners held 2,365 shares of Thermo Fisher Scientific worth $1.16M as of Q1 2026.
  • Riverwater Partners bought 57 Thermo Fisher Scientific shares in Q1 2026, an estimated $30.9K.
  • Thermo Fisher Scientific made up 0.39% of Riverwater Partners's portfolio in Q1 2026, its #82 holding.
  • Riverwater Partners first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • Riverwater Partners's Thermo Fisher Scientific position peaked at $1.44M in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Riverwater Partners's 13F filing for Q1 2026, filed 8 May 2026.